Search results
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks via Yahoo Finance· 3 days agoIt enables early interactions between the FDA and sponsors to facilitate accelerated approval and...
ORPHAN Cures | Pacific Sun
Pacific Sun· 4 days agoAdding insult to illness, an element of 2022’s Inflation Reduction Act (IRA) discourages research into treatments for rare conditions. The good news is that Congress can undo this unintended ...
SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX...
FOX 23 News Albany· 5 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Calliditas Q1 report, January - March 2024
FOX 59 Indianapolis· 3 days agoNet sales amounted to SEK 295.5 million, of which TARPEYO® net sales amounted to SEK 278.3 million, for the three months ended March 31, 2024. For the...
Biogen to acquire HI-Bio for up to $1.8 billion By Investing.com
Investing.com· 4 days agoHI-Bio's lead asset, felzartamab, is an anti-CD38 monoclonal antibody with Breakthrough Therapy...
How patient advocacy can lead to more successful and meaningful clinical trials
Clinical Trials Arena via Yahoo Finance· 6 days agoBut this is not an endpoint that the US Food and Drug Administration (FDA) considers as meaningful...
Q1 2024 Biomx Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoIn January this year, we were granted Orphan Drug Designation by the FDA for BX004. More recently, in April, we presented positive safety ...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 2 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest...
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks· 6 days agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in liver disease progression and reduced itching in primary biliary cholangitis study.
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From...
FOX 59 Indianapolis· 6 days agoThe Company will share the data with an international audience of patient advocacy groups, physicians, research organizations, industry representatives, key thought leaders and decision makers ...
